GLP-1 & GIP Mechanisms Incretin Comparative Review (PubMed, 2024) Two-Incretin Model: GLP-1 and GIP Receptor Signalling Across Pancreas, Brain, Liver, and Adipose Tissue A comparative review of GLP-1 and GIP receptor mechanisms published on PubMed in 2024 documented the complete receptor-level biology of both incretins across multiple tissues
& Lodish, H
While marketed as GLP-1 support, they provide no prescription medication and cannot truly replicate the proven effects of real prescription GLP-1 therapies, which have proven to be effective at listing 15% or more of your starting weight
Kawatani, M., Itoi, K., Talukder, A
But it was no longer in shortage per the FDA as of April 2025, making continued compoundingan extremely bold move.2 Meanwhile, Novo Nordisk, the manufacturer of Wegovy and Ozempic, was building its argument against compounded GLP-1s